CJC-1295 NO DAC + GHRP Blend

CJC-1295 NO DAC + GHRP Blend Peptide Vials

Product Composition:

• CJC-1295 NO DAC + GHRP-2 Blend: Contains 2 mg of CJC-1295 No DAC and 2 mg of GHRP-2, totaling 4 mg.​

• CJC-1295 NO DAC + GHRP-6 Blend: Contains 2 mg of CJC-1295 No DAC and 2 mg of GHRP-6, totaling 4 mg.​

Component Details:

CJC-1295 No DAC (Modified GRF 1-29):

• CAS Number: 86168-78-7​

• Molar Mass: 3357.93 g·mol−1​

• Chemical Formula: C149H246N44O42S​Kimera Chems

• IUPAC Name: L-Tyrosyl-L-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucylglycyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-methionyl-L-seryl-L-argininamide​

GHRP-6:

• CAS Number: 87616-84-0​

• Molar Mass: 873.032 g·mol−1​

• Chemical Formula: C46H56N12O6​ChemSpider

• IUPAC Name: L-Histidyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysin-amide​

Introduction:

CJC-1295 NO DAC + GHRP Blend Vials are advanced research products formulated exclusively for scientific studies. These vials combine CJC-1295 (without DAC) and Growth Hormone-releasing peptides (GHRPs), both recognized for their potential roles in modulating growth hormone secretion.​

Key Characteristics:

This product merges CJC-1295, a modified Growth Hormone-Releasing Hormone (GHRH) analog, with GHRPs. The absence of the Drug Affinity Complex (DAC) in CJC-1295 results in a shorter half-life, potentially leading to a more pulsatile release of growth hormone when combined with GHRPs.​

Research Applications:

The CJC-1295 NO DAC + GHRP Blend Vials provide researchers with a means to investigate the complex mechanisms governing growth hormone regulation. The synergistic combination of CJC-1295 and GHRPs offers a unique opportunity to study their collective effects on growth hormone secretion and their potential implications in various physiological processes.​

Research Benefits:

• Elevated Growth Hormone Levels: Studies have demonstrated that combining CJC-1295 NO DAC with GHRPs can lead to increased growth hormone levels, offering valuable insights into the hormone’s influence on diverse physiological functions.​

• Regulation of Growth Hormone Secretion: This blend has shown potential in normalizing growth hormone levels, aiding in the understanding of mechanisms that maintain hormonal balance.​

• Cardiovascular Research: Preliminary findings suggest that the CJC-1295 NO DAC + GHRP blend may positively affect cardiac function, opening new avenues for cardiovascular research.​

Disclaimer:

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.​

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).​

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.​

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer satisfaction is our paramount concern. If you are dissatisfied with the product received, please contact us at 419-707-5450 or email our support team at support@bc9.co.​

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human use.

References:

1. Micic D, Popovic V, Kendereski A, Macut D, Casanueva FF, Dieguez C. Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood. Clin Endocrinol (Oxf). 1995 Feb;42(2):191-4. doi: 10.1111/j.1365-2265.1995.tb01861.x. PMID: 7734029. [Read More]
2. Bowers, C.Y., Laferrére, B., Hurley, D.L., Veldhuis, J.D. (2007). The Role of Growth Hormone Secretagogues and Ghrelin in Feeding and Body Composition. In: Donohoue, P.A. (eds) Energy Metabolism and Obesity. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-60327-139-4_8. [Read More]